Depletion study of enrofloxacin and its metabolite ciprofloxacin in edible tissues and feathers of white leghorn hens by liquid chromatography coupled with tandem mass spectrometry

被引:70
作者
Martin, B. San [1 ]
Cornejo, J.
Iraguen, D.
Hidalgo, H.
Anadon, A.
机构
[1] Univ Chile, Coll Vet Sci, Lab Vet Pharmacol, Santiago, Chile
[2] Univ Chile, Coll Vet Sci, Lab Avian Pathol, Santiago, Chile
[3] Univ Complutense Madrid, Coll Vet Med, Dept Toxicol & Pharmacol, Madrid 08040, Spain
关键词
D O I
10.4315/0362-028X-70.8.1952
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To ensure delivery of safe foods to consumers, withdrawal times for drugs must be respected according to the maximum residual limits established by regulatory agencies. Because of availability and price, feather meal is currently incorporated into animal feed as a protein source for farm species. Few data are available on residual drugs in feathers from treated animals. A depletion study was performed with laying hens treated intramuscularly with 5% enrofloxacin (Enromic) at 10 mg/kg body weight over 3 days. Thirty-three birds were treated and slaughtered at different times between 6 and 216 It after treatment; and samples of muscle plus skin, liver, kidney, and feathers were collected. High-performance liquid chromatography coupled with a tandem mass spectrometry method was validated before sample analysis to determine the decision limit, detection capability, recovery, and precision. Liver was the edible tissue with the slowest drug depletion. A withdrawal time of 6 days was calculated based on European Union maximum residual limits (100 mu g/kg). A withdrawal time of 9 days was calculated based on Japan maximum residual limits (10 mu g/kg). Enrofloxacin plus ciprofloxacin concentrations in feathers remained high through all sampling periods. Thus, feathers from treated animals should not be fed to food-producing animals.
引用
收藏
页码:1952 / 1957
页数:6
相关论文
共 39 条
[1]  
ANADON A, 1995, AM J VET RES, V56, P501
[2]   Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens [J].
Anadón, A ;
Martínez-Larrañaga, MR ;
Iturbe, J ;
Martínez, MA ;
Díaz, MJ ;
Frejo, MT ;
Martínez, M .
RESEARCH IN VETERINARY SCIENCE, 2001, 71 (02) :101-109
[3]   Development of the quinolones [J].
Andersson, MI ;
MacGowan, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 :1-11
[4]  
[Anonymous], 1990, OFFICIAL J L, V224, P0001
[5]  
Aydemir S, 2006, W INDIAN MED J, V55, P9
[6]   A biotechnological process for treatment and recycling poultry feathers as a feed ingredient [J].
Bertsch, A ;
Coello, N .
BIORESOURCE TECHNOLOGY, 2005, 96 (15) :1703-1708
[7]   Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in male and female turkeys following intravenous and oral administration [J].
Dimitrova, DJ ;
Lashev, LD ;
Yanev, SG ;
Pandova, VT .
VETERINARY RESEARCH COMMUNICATIONS, 2006, 30 (04) :415-422
[8]  
ELLIS R, 2004, JOINT FAO WHO TECHN
[9]   Antimicrobial susceptibility of Salmonella isolated from cattle, swine and poultry (2001-2002):: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program [J].
Esaki, H ;
Morioka, A ;
Ishihara, K ;
Kojima, A ;
Shiroki, S ;
Tamura, Y ;
Takahashi, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) :266-270
[10]  
*EUR AG MED, 1995, EMEACVMP03695